Handelsbanken Fonder
ONC

Handelsbanken Fonder’s BeOne Medicines Ltd ONC Stock Holding History

Handelsbanken Fonder’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-26,370
Closed -$5.92M – 1580
2024
Q3 		$5.92M Hold
26,370
– – 0.02% 411
2024
Q2 		$3.76M Buy
26,370
+5,616
+27% +$866K 0.02% 455
2024
Q1 		$3.25M Sell
20,754
-526
-2% -$84.7K 0.01% 503
2023
Q4 		$3.84M Sell
21,280
-6,529
-23% -$1.18M 0.02% 459
2023
Q3 		$5M Buy
27,809
+400
+1% +$79.1K 0.03% 421
2023
Q2 		$4.89M Buy
27,409
+400
+1% +$92.1K 0.03% 430
2023
Q1 		$5.82M Buy
27,009
+1,890
+8% +$453K 0.03% 399
2022
Q4 		$5.53M Buy
25,119
+3,266
+15% +$599K 0.03% 402
2022
Q3 		$2.95M Buy
21,853
+2,053
+10% +$353K 0.02% 478
2022
Q2 		$3.21M Buy
19,800
+2,300
+13% +$359K 0.02% 478
2022
Q1 		$3.3M Buy
17,500
+1,000
+6% +$213K 0.02% 512
2021
Q4 		$4.47M Sell
16,500
-2,800
-15% -$945K 0.02% 495
2021
Q3 		$7.01M Buy
19,300
+700
+4% +$229K 0.04% 414
2021
Q2 		$6.38M Buy
18,600
+1,300
+8% +$431K 0.03% 440
2021
Q1 		$6.02M Buy
17,300
+1,700
+11% +$563K 0.03% 393
2020
Q4 		$4.03M Buy
15,600
+3,600
+30% +$991K 0.02% 454
2020
Q3 		$3.44M Hold
12,000
– – 0.03% 438
2020
Q2 		$2.26M Buy
+12,000
New +$1.95M 0.02% 502

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Handelsbanken Fonder's ONC Position: Q4 2024 in Review

Handelsbanken Fonder sold out of BeOne Medicines Ltd (ONC) in Q4 2024, closing a stake of 26,370 shares — an estimated $5.92M sold.

Handelsbanken Fonder first reported a position in ONC in Q2 2020 and held it in 18 quarters. The position peaked at $7.01M in Q3 2021. 228 funds tracked by Wall St. Rank hold ONC as of Q4 2024.

  • Handelsbanken Fonder reported no remaining BeOne Medicines Ltd position as of Q4 2024 after selling out during the quarter.
  • Handelsbanken Fonder sold 26,370 BeOne Medicines Ltd shares in Q4 2024, an estimated $5.92M.
  • Handelsbanken Fonder first reported a position in BeOne Medicines Ltd in Q2 2020 and held it in 18 quarters.
  • Handelsbanken Fonder's BeOne Medicines Ltd position peaked at $7.01M in Q3 2021.
  • 228 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2024.

Based on Handelsbanken Fonder's 13F filing for Q4 2024, filed 3 Feb 2025.